Search Results

If you make changes to this saved search, you'll find the original and new searches in your account.

Your search filters:

Lab150

Showing 1-3 of about 3 articles.

MaRS Innovation

MaRS Innovation adds to growing portfolio with two new LAB150 projects to create novel therapeutics for Cystic Fibrosis and Respiratory Syncytial Virus.

Toronto, ON, Feb. 27, 2019 (GLOBE NEWSWIRE) -- MaRS Innovation announced today the concurrent launch of two new LAB150 projects. These projects build on breakthroughs in disease-focused scientific...

February 27, 2019

MaRS Innovation

LAB150 awards its second drug discovery project from Canada’s largest research based Hospital, The University Health Network (UHN)

Toronto, ON, Oct. 04, 2018 (GLOBE NEWSWIRE) -- MaRS Innovation announced today the second project to be developed under their LAB150 partnership with Evotec. The project aims to develop a...

October 04, 2018 photo-release

MaRS Innovation

EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE

Hamburg, Germany, and Toronto, Canada, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and MaRS Innovation announced today that they have...

February 15, 2018 photo-release

Showing 1-3 of about 3 articles.

MaRS Innovation adds to growing portfolio with two new LAB150 projects to create novel therapeutics for Cystic Fibrosis and Respiratory Syncytial Virus.

LAB150 awards its second drug discovery project from Canada’s largest research based Hospital, The University Health Network (UHN)

EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE

Newswire Distribution Network & Management

About Us